BioSpace News Archive

Pharm Country

What’s Happening with These Biotech Stocks? -- Aeterna Zentaris, Affimed, Agenus, and Agios Pharma

WallStEquities.com is offering reports on AEZS, AFMD, AGEN, and AGIO.

March 13, 2018
·
4 min read
Policy

AbCellera Awarded Multi-Year Contract to Lead the Development of a Rapid Response Platform Against Pandemic Viral Threats

AbCellera Biologics Inc. announced that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop rapid countermeasures against viral outbreaks.

March 13, 2018
·
2 min read
Biotech Bay

Study Shows Nurse Practitioners and Physicians Face Similar Liability Risks

A study issued today by The Doctors Company reveals that the allegations in medical malpractice claims against nurse practitioners (NPs) do not differ radically from those made against primary care physicians.

March 13, 2018
·
1 min read
Drug Development

Biostage Preclinical Study Results Published in New Report

Large-animal study results published in Nature Scientific Reports show successful esophageal regeneration.

March 13, 2018
·
3 min read
Business

Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results

Full-Year Net Revenues Increased to $105.9 Million Versus $54.3 Million in Full-Year 2016.

March 13, 2018
·
33 min read
Business

GRYT Health and Bristol-Myers Squibb Announce New Digital Pilot to Advance Cancer Care through Patient-Driven Insights

Utilizes de-identified data to integrate patient insights and clinical research with the goal of building a foundation of real-world data that will support improved clinical trial design, disease management and the overall well-being of patients living with cancer.

March 13, 2018
·
3 min read
FDA

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer

First filing acceptance for an Anti-PD-1 Therapy in cervical cancer.

March 13, 2018
·
22 min read
Business

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Announced today financial and operational results for the three and twelve months ended December 31, 2017.

March 13, 2018
·
13 min read
Business

Sosei Regains Worldwide Rights from Teva to Develop and Commercialize Novel Small Molecule CGRP Antagonists for Migraine and Other Severe Headaches

Sosei Group announced that it has regained worldwide rights from Teva Pharmaceutical Industries Limited to develop and commercialize lead candidate HTL0022562 and other novel small molecule CGRP antagonists for the treatment of migraine and other severe headaches.

March 13, 2018
·
3 min read
Business

Barre3 Brings Whole-Health Fitness to Workplace Wellness

Peerfit announced a new partnership with barre franchise, barre3.

March 13, 2018
·
2 min read